Use of pembrolizumab in MSI-high uterine leiomyosarcoma; a case report and review of the literature

Yannan J. Wang, Heather R. Williams, Bogna N. Brzezinska, Anna Gaidis, Bhavi Patel, Janet Munroe, Joseph White, Bunja Rungruang

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article number100701
JournalGynecologic Oncology Reports
Volume35
DOIs
StatePublished - Feb 2021

Keywords

  • Immune checkpoint inhibitors
  • Microsatellite instability
  • Pembrolizumab
  • Uterine leiomyosarcoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this